TY  -  
T1  - European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sezary syndrome - Update 2017 
SN  -  /  
UR  - http://hdl.handle.net/10138/197451 
T3  -  
A1  - Trautinger, Franz; Eder, Johanna; Assaf, Chalid; Bagot, Martine; Cozzio, Antonio; Dummer, Reinhard; Gniadecki, Robert; Klemke, Claus-Detlev; Ortiz-Romero, Pablo L.; Papadavid, Evangelia; Pimpinelli, Nicola; Quaglino, Pietro; Ranki, Annamari; Scarisbrick, Julia; Stadler, Rudolf; Vakeva, Liisa; Vermeer, Maarten H.; Whittaker, Sean; Willemze, Rein; Knobler, Robert 
A2  -  
PB  -  
Y1  - 2017 
LA  - eng 
AB  - In order to provide a common standard for the treatment of mycosis fungoides (MF) and Sezary syndrome (SS), the European Organisation for Research and Treatment of Cancer-Cutaneous Lymphoma Task Force (EORTC-CLTF) published in 2006 its consensus recommendations for the stage-adapted selection of management options for these neoplasms. Since then, the understanding of the pathophysiology and epidemiology of MF/SS has advanced, the staging system has been revised, new outcome data have been publis... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Mycosis fungoides; Sezary syndrome; Cutaneous T-cell lymphomas; Skin-directed therapy; Total skin electron beam therapy; Radiotherapy; Phototherapy; Chemotherapy; Immunotherapy; Retinoids; T-CELL LYMPHOMA; SKIN ELECTRON-BEAM; PEGYLATED LIPOSOMAL DOXORUBICIN; PHASE-II TRIAL; ORAL METHOXSALEN-PHOTOCHEMOTHERAPY; HISTONE DEACETYLASE INHIBITORS; BONE-MARROW-TRANSPLANTATION; TOPICAL NITROGEN-MUSTARD; LOW-DOSE BEXAROTENE; ALPHA-2A PLUS PUVA; 3122 Cancers; 3121 General medicine, internal medicine and other clinical medicine 
N1  -   
PP  -  
ER  -